Gokhan Tut

University of Birmingham - Institute of Immunology and Immunotherapy

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 11,396

SSRN RANKINGS

Top 11,396

in Total Papers Downloads

5,182

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1

Number of pages: 15 Posted: 13 Apr 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Clinical Immunology Service, University Hospitals Birmingham NHS Foundation Trust, Harborne Medical Practice, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, University of Birmingham - Clinical Immunology Service and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 3,952 (3,032)
Citation 1

Abstract:

Loading...

Vaccination, SARS-CoV-2, COVID, Antibody, Cellular, mRNA, ChAdOx1

2.

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Number of pages: 24 Posted: 31 Mar 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Immunology and Immunotherapy, Quinton and Harborne PCN, University of Birmingham - Institute of Immunology and Immunotherapy, Deparment of Buisness Energy and Industrial Strategy - Vaccine Taskforce, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England, Public Health England - National infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England - National Infection Service, Oxford Immunotec LTD, University of Birmingham - Clinical Immunology Service and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,008 (27,081)

Abstract:

Loading...

Vaccination. SARS-CoV-2. COVID. Immunosenescence. Antibody. T-cell. Variant. Neutralisation. Ageing. Immunisation

3.

Vaccine Effectiveness of the First Dose of ChAdox1 nCOV-19 and BNT162b2 Against SARS-CoV-2 Infection in Residents of Long Term Care Facilities (VIVALDI Study)

Number of pages: 24 Posted: 07 Apr 2021
Public Health England Colindale, University College London - Institute for Health Informatics, University College London - Institute for Global Health, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, Public Health England, University College London - Institute for Health Informatics, Department of Health and Social Care, Palantir Technologies, University of Birmingham - Institute of Immunology and Immunotherapy, Public Health England Colindale, University College London - Research Department of Epidemiology & Public Health, University College London - Institute for Global Health and University College London - Institute for Health Informatics
Downloads 128 (271,639)

Abstract:

Loading...

4.

Profile of Humoral and Cellular Immune Responses to Single BNT162b2 or ChAdOx1 Vaccine in Residents and Staff Within Residential Care Homes (VIVALDI Study)

Number of pages: 17 Posted: 04 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - UCL Institute of Health Informatics, University College London - Institute for Health Informatics, University College London - UCL Institute of Health Informatics, Department of Health and Social Care, University College London - Research Department of Epidemiology & Public Health, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 94 (336,746)
Citation 1

Abstract:

Loading...